Dr Alec Miners BA MSc PhD
- Alec Miners's Contacts
- Room 134
- 15-17 Tavistock Place
- WC1H 9SH
- T: 0207 927 2069
Following graduation from the MSc in Health Economics at York, Alec worked for 5 years at the Royal Free Medical School, London. His main work / thesis project was on a study assessing the cost-effectiveness of different treatments for people with clotting factor disorders. He then went on to work at the National Institute for Health and Clinical Excellence as a Technical Advisor and as a honorary Research Fellow at Brunel University, before joining the LSHTM in 2006.
He was a member of NICE's Technology Appraisals Committee between 2007 and 2015 and is a current member of its Decision Support Unit
Alec lectures and is a seminar leader on Introduction to Health Economics and Economic Evaluation
His main research interests are in assessing the cost-effectiveness of HIV / STIs treatments and methods of prevention, mainly from a high income perspective. He is also interested in patient preferences regarding HIV / STI service configurations.
- Decision analysis
- Economic evaluation
- Public health
Disease and Health Conditions
- Infectious disease
- Sexually transmitted disease
- Sexually transmitted infection
- European Union
Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries.
Cambiano, V. ; Ford, D. ; Mabugu, T. ; Napierala Mavedzenge, S. ; Miners, A. ; Mugurungi, O. ; Nakagawa, F. ; Revill, P. ; Phillips, A. ;
J Infect Dis, 2015;
Projected Lifetime Healthcare Costs Associated with HIV Infection.
Nakagawa, F. ; Miners, A. ; Smith, C.J. ; Simmons, R. ; Lodwick, R.K. ; Cambiano, V. ; Lundgren, J.D. ; Delpech, V. ; Phillips, A.N. ;
PLoS One, 2015; 10(4):e0125018
Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings.
Phillips, A. ; Cambiano, V. ; Nakagawa, F. ; Magubu, T. ; Miners, A. ; Ford, D. ; Pillay, D. ; De Luca, A. ; Lundgren, J. ; Revill, P. ;
PLoS One, 2014; 9(10):e109148
Assessing user preferences for sexually transmitted infection testing services: a discrete choice experiment.
Miners, A.; Llewellyn, C.; Pollard, A.; Lagarde, M.; Richardson, D.; Cairns, J.; Fisher, M.; Smith, H.;
Sex Transm Infect, 2012; 88(7):510-6
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring
von Wyl, V.; Cambiano, V.; Jordan, M.R.; Bertagnolio, S.; Miners, A.; Pillay, D.; Lundgren, J.; Phillips, A.N.
PLoS One, 2012; 7(8):e42834
The cost-effectiveness of HCV antiviral treatment for injecting drug user populations.
Martin, N.K.; Vickerman, P.; Miners, A.; Foster, G.R.; Hutchinson, S.J.; Goldberg, D.J.; Hickman, M.;
Hepatology, 2011; 55(1):49-57
Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model
Phillips, A.N.; Pillay, D.; Miners, A.H.; Bennett, D.E.; Gilks, C.F.; Lundgren, J.D.
Lancet, 2008; 371(9622):1443-1451
Assessing the cost-effectiveness of HAART for adults with HIV in England.
Miners, A.H.; Sabin, C.A.; Trueman, P.; Youle, M.; Mocroft, A.; Johnson, M.; Beck, E.J.;
HIV Med, 2001; 2(1):52-8
- → View all Dr Alec Miners 's publications